You are here

Article Text

Article menu

Download PDFPDF

Correspondence
Semiquantitative analysis of line blot assay for myositis-specific and myositis-associated antibodies: a better performance?
Free
  1. Ilaria Cavazzana1,
  2. Micaela Fredi1,2,
  3. Franco Franceschini1,2
  1. 1 Rheumatology and Clinical Immunology Unit, ASST Spedali Civili of Brescia, Brescia, Italy
  2. 2 Department of Clinical and Experimental Science, University of Brescia, Brescia, Italy
  1. Correspondence to Dr Ilaria Cavazzana, Rheumatology and Clinical Immunology, ASST Spedali Civili of Brescia, Brescia 25100, Italy; ilariacava{at}virgilio.it

https://doi.org/10.1136/annrheumdis-2019-215884

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We read with interest the letter of Espinosa-Ortega F et al 1 comparing line immunoblot assay (LIA) and immunoprecipitation (IP) performance in the detection of myositis-specific antibody (MSA) and myositis-associated antibody (MAA). The authors found a global moderate agreement between tests, with a very good agreement for anti-signal recognition particle (SRP), anti-Ku and anti-small ubiquitin-like modifier activating enzyme (SAE1); a good agreement for anti-hystidil-tRNA synthetase (Jo-1) and a moderate agreement for anti-PM/Scl, anti-melanoma differentiation-associated gene 5 (MDA5) and anti-transcription intermediary factor 1 (TIF1 gamma). …

    View Full Text

    Linked Articles